Session #1 of our four-part Virtual Grand Round Series. This series is designed to support site education, patient identification, and readiness for medical therapy trial opportunities with the moderate aortic stenosis patients. What You'll Learn: -- Describe key physiologic and structural markers of disease progression in moderate AS -- Identify clinical and imaging features that indicate higher risk for accelerated progression -- Explain the rationale for earlier identification of “at-risk” moderate AS patients for potential trial screening. -- Apply real-world clinical data to determine when patients may benefit from specialty evaluation or research consideration.

Cardiovascular Risk Beyond Traditional Predictors: The Independent Role of UACR and eGFR
245 views

Rural at Heart Community Connector in Pine Bluff, Arkansas
234 views

Building the Advanced Heart Failure Pipeline
122 views

Understanding Amyloidosis & Emerging Therapeutic Frontiers
35 views

Breakthroughs in ATTR-CM: CRISPR-Cas9 and the Evolving Trial Landscape
21 views

He learned CPR, then saved his friend's life: Wallis' Story
31 views